The effect of p53 and p21WAF-1, two well established effectors of the senescence program, was studied in two inducible osteosarcoma cell lines, namely Saos-2 p21-Tet-ON and Saos-2 p53-Tet-ON [21-24]. This evidence concerns the gene TP53 and osteosarcoma.